LEADERSHIP TEAM
Srinath Rangarajan, Ph.D.
Founder
Srinath brings over 15 years of experience in the life-science and medical diagnostic device industries and is passionate about science and innovation, health and wellbeing, sustainability and business strategy. He is a two-time founder at Asima Health and Yoga Vidya. He loves troubleshooting, working with cross-functional teams and in bringing about innovation. Srinath has a Ph.D. in Chemical engineering from the University of Utah and did his postdoctoral research at Duke University and at the University of Washington (in bioengineering).
Catherine Martel, Ph.D.
Catherine is a biotechnology and bioprocessing expert with over 15 years of experience in biologics, cell and gene therapy, and upstream process development. She holds a Ph.D. in Molecular Biology from Cornell University. Her core expertise includes CRISPR gene editing, lentiviral-based genetic engineering, and bioreactor optimization for biologics production and cell and gene therapy applications. She is passionate about developing scalable bioprocesses and advancing innovative therapies to drive breakthroughs in the biopharma industry.
Sriram Rangarajan, M.S.
Sriram is an experienced life-science consultant. He brings over 20 years of experience in pharmaceutical sales strategies, and in leading global data analytics teams. He was previously a senior principal at 159 Solutions (acquired by IQVIA) and built his career at ZS Associates. He has a masters from the University of Wisconsin in Industrial Engineering. Sriram has robust set of skills including Requirements Analysis, Analytics, C, SQL, MATLAB, Process Engineering and Six Sigma.
Kavitha Ranganathan, MS
​Kavitha is a seasoned industry veteran bringing her expertise in commercial product launch strategy portfolio, to Praclia. She is a patient centric, highly analytical, and detailed oriented commercial leader with more than 12 years in pharmaceutical industry with expertise in project management, HCP and patient marketing roles, and leading multiple commercial launches in hematology, oncology and solid tumors.